Cholesterol Pathway Gene Variants and Reduced Keratinocyte Cholesterol Support a Final Common Druggable Pathway in Hyperproliferative Inflammatory Skin Diseases
Melissa Riachi(University College London), Veronica A. Kinsler(Great Ormond Street Hospital), Connor Hughes(The Francis Crick Institute), Noreen Muwanga-Nanyonjo(Great Ormond Street Hospital), Nicole Knöpfel(Great Ormond Street Hospital), James K. Ellis(The Francis Crick Institute), Ignacio del Valle(The Francis Crick Institute), Youssef Khalil(University College London), Michael A. Simpson(King's College London), Satyamaanasa Polubothu(Great Ormond Street Hospital), Dale Bryant(Great Ormond Street Hospital), Mariana Silva dos Santos(The Francis Crick Institute), Alicia L. Bruzos(Centre National de la Recherche Scientifique), Peter T. Clayton(Institute of Child Health), Sara Barberan-Martin(Great Ormond Street Hospital), Gavin Kelly(The Francis Crick Institute), Susana A. Palma-Duran(Food Research and Development Institute), Aimie Sauvadet(Great Ormond Street Hospital), Enrica Calvani(The Francis Crick Institute), Wei-Li Di(King's College London), Philippa B. Mills(University College London), Charlotte Chaloner(King's College London), James I. MacRae(The Francis Crick Institute), Neil Bulstrode(Great Ormond Street Hospital), Patricia Barral(Hospital Ramos Mejía), James Lee(Royal Free London NHS Foundation Trust), Nick Dand(King's College London)
Cited by 2
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k